P-ISSN 2587-2400 | E-ISSN 2587-196X
Contact
EJMO Home
|
Toggle navigation
EJMO HOME
ABOUT JOURNAL
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
FOR REVIEWERS
EJMO ARCHIVE
CONTACT
EJMO Volume :
7
Issue :
1
Year :
2023
COVID-19 in EJMO
7/1
EJMO Current Issue
EJMO Archive
EJMO & Congress
Most Cited Articles
Ahead of Print
Most Accessed Articles
Copyright Transfer Form
ICMJE COI Form
EJMO Sponsors
Glead
Pfizer
Roche
Amgen
Astellas
Bristol-Myers Squibb
Arven
Johnson Johnson
Merck
Novartis
Omnigen
Mustafa Nevzat
TEVA
Trpharm
Sandoz
What can we do to help recovery, Earthquake in Turkey---->>>
Page not found.
Submit Manuscript
WEB OF SCİENCE click
Impact Factor:
Awaiting in 2023
Journal Citation Indicator :
0.39
Medicine, General & Internal:
Q2
135/329
SCOPUS click
CiteScoreTracker 2022:
0.8
CiteScore year 2021:
0.2
Google Scholar click
Number of Articles:
315
Citations:
2336
h-index:
15
i10-index:=
21
EJMO NLM ID:
101720527
Accept Ratio :
18.2 %
Final decision avg
34 day
Quick Search
In authors and institutes
In titles and abstracts
In keywords
In all
Copyright © 2023 Eurasian Journal of Medicine and Oncology, EJMO
EJMO & EJMO